6-{2-amino-6-[(2R)-2-methyl-1-piperidinyl]-4-pyrimidinyl}-1H-indazol-3-amine | 1271022-83-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡唑类
• 英文名称: 6-{2-amino-6-[(2R)-2-methyl-1-piperidinyl]-4-pyrimidinyl}-1H-indazol-3-amine
• 英文别名: (R)-6-(2-Amino-6-(2-methylpiperidin-1-yl)pyrimidin-4-yl)-1H-indazol-3-amine；6-[2-amino-6-[(2R)-2-methylpiperidin-1-yl]pyrimidin-4-yl]-1H-indazol-3-amine
• CAS: 1271022-83-3
• 化学式: C₁₇H₂₁N₇
• 分子量: 323.401
• InChiKey: XWODEDHTMYVLNJ-SNVBAGLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  110
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  (R)-(-)-2-甲基哌啶 在 四(三苯基膦)钯 、 碳酸氢钠 、 一水合肼 作用下， 以 1,4-二氧六环 、 甲醇 、 乙醇 、 水 为溶剂， 生成 6-{2-amino-6-[(2R)-2-methyl-1-piperidinyl]-4-pyrimidinyl}-1H-indazol-3-amine
  参考文献：
  名称：

  Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors

  摘要：

  Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component of the PI3K/AKT/mTOR pathway. As this pathway is among the most commonly deregulated across all cancers, a selective inhibitor of PDKI might have utility as an anticancer agent. Herein we describe our lead optimization of compound 1 toward highly potent and selective PDKI inhibitors via a structure-based design strategy. The most potent and selective inhibitors demonstrated submicromolar activity as measured by inhibition of phosphorylation of PDK1 substrates as well as antiproliferative activity against a subset of AML cell lines. In addition, reduction of phosphorylation of PDK1 substrates was demonstrated in vivo in mice bearing OC1-AML2 xenografts. These observations demonstrate the utility of these molecules as tools to further delineate the biology of PDKI and the potential pharmacological uses of a PDK1 inhibitor.

  DOI：

  10.1021/jm101527u